4F-Phenyl Pyrazole Induces Apoptotic Cell Death in T84 Colorectal Cancer Cells
Keywords:
4F-phenyl pyrazole, [6]-shogaol, Colorectal cancer, ApoptosisAbstract
Colorectal cancer is the second most common cancer globally and the third leading cause of cancer death. A delayed diagnosis and high cost of treatment contribute to high mortality. Thai herbs have gained more interest as chemopreventive agents. Ginger is one of the most widely studied herbs composing of many bioactive compounds for treating diseases, including [6]-shogaol. Previous studies have reported that [6]-shogaol exhibited antiproliferative activity against various human cancer cells. However, its therapeutic effects were limited due to physicochemical properties. Therefore, the present study aimed to investigate the antiproliferative activity of [6]-shogaol derivatives including PK4F1, PK2ME and PK4NO2, on human colorectal (T84) cancer cells. Morphological analysis of T84 cells under a microscope revealed that PK4F1, or 4F-phenyl pyrazole, exhibited strong antiproliferative effects compared to PK2ME and PK4NO2. The morphological changes observed were comparable to those induced by [6]-shogaol. In addition, PK4F1 possessed a tremendous effect on inhibiting colony formation. Cells viability assays showed a reduction in T84 cells viability with an IC50 of 16.76 µM. Flow cytometry assay showed that treatment with 20 µM of PK4F1 significantly increased apoptotic cell death. Moreover, fluorescence microscopy revealed that PK4F1 could induce phosphatidyl serine exposure chromatin condensation and DNA fragmentation, a hallmark of apoptosis. These findings suggested that PK4F1 inhibited the growth of T84 cells in dose-dependent manner by inducing apoptosis. Therefore, PK4F1 might be a promising candidate for further development as an anti-colorectal cancer agent. Additional studies are required to elucidate its underlying mechanisms.
References
Benson AB, Venook AP, Adam M, et al. Colon cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. JNatl Compr Cancer Netw 2024; 22(2D): e240029.
Sung H, Siegel RL, Laversanne M, et al. Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. Lancet Oncol 2025; 26:
-63.
Hossain MS, Karuniawati H, Jairoun AA, et al. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers (Basel) 2022; 14: 1732.
Eng C, Yoshino T, Ruíz-García E, et al. Colorectal cancer. Lancet 2024; 404: 294-310.
Chakraborty D, Bishayee K, Ghosh S, Biswas R, Kumar Mandal S, Rahman Khuda-Bukhsh A. [6]-Gingerol induces caspase 3 dependent apoptosis and autophagy in cancer cells: Drug-DNA interaction and expression of certain signal genes in HeLa cells. Eur J Pharmacol 2012; 694: 20-9.
Lee SH, Cekanova M, Baek SJ. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog 2008; 47: 197-208.
Radhakrishnan EK, Bava SV, Narayanan SS, et al. [6]-Gingerol induces caspase-dependent apoptosis and prevents PMA-induced proliferation in colon cancer cells by inhibiting MAPK/AP-1 Signaling. PLoS One 2014; 9: e104401.
Liu C-M, An L, Wu Z, et al. 6-Gingerol suppresses cell viability, migration and invasion via inhibiting EMT, and inducing autophagy and ferroptosis in LPS‑stimulated and LPS‑unstimulated prostate cancer cells. Oncol Lett 2022; 23: 187.
Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495-516.
Shah P, Westwell AD. The role of fluorine in medicinal chemistry. J Enzyme Inhib Med Chem 2007; 22: 527-40.
Huo T, Zhao X, Cheng Z, et al. Late-stage modification of bioactive compounds: Improving druggability through efficient molecular editing. Acta Pharm Sin B 2024; 14: 1030-76.
Henary E, Casa S, Dost TL, Sloop JC, Henary M. The role of small molecules containing fluorine atoms in medicine and imaging applications. Pharmaceuticals 2024; 17: 281.
Shah P, Westwell AD. The role of fluorine in medicinal chemistry. J Enzyme Inhib Med Chem 2007; 22: 527-40.
Zhang H, Wang Q, Sun C, et al. Enhanced oral bioavailability, anti-tumor activity and hepatoprotective effect of 6-shogaol loaded in a type of novel micelles of polyethylene glycol and linoleic acid conjugate. Pharmaceutics 2019; 11.
Liew SK, Malagobadan S, Arshad NM, Nagoor NH. A review of the structure-activity relationship of natural and synthetic antimetastatic compounds. Biomolecules 2020; 10.
Kalariya R, Ojha D, Rana S, Rode A, Bhosale R, Yadav JS. Novel fluorinated amino acid derivatives as potent antitumor agents against MCF-7 and HepG2 cells: Synthesis, characterization, in vitro assays and molecular docking studies. Results Chem 2023; 5: 100954.
Phaosiri C, Yenjai C, Senawong T, et al. Histone deacetylase inhibitory activity and antiproliferative potential of new [6]-shogaol derivatives. Molecules 2022; 27.
Jia Y, Li X, Meng X, Lei J, Xia Y, Yu L. Anticancer perspective of 6-shogaol: anticancer properties, mechanism of action, synergism and delivery system. Chin Med 2023; 18: 138.
Sirianant L, Wanitchakool P, Kumboonma P, Srisarakorn N, Hempoom P, Muanprasart C. Effects of 4f-phenyl pyrazole, a [6]-shogaol derivative, on colorectal adenocarcinoma cell death. Sci. Asia 2025; 51: 1-10.
Kunzelmann K, Nilius B, Owsianik G, et al. Molecular functions of anoctamin 6 (TMEM16F): a chloride channel, cation channel, or phospholipid scramblase? Pflugers Arch 2014; 466: 407-14.
Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010; 468: 834-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Journal of the Medical Technologist Association of Thailand

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.